Companies Dominating the Rheumatic Myocarditis Treatment Landscape
- Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- CryoLife Inc.
- Edwards Lifesciences Corporation
- Neovasc Inc.
- HighLife SAS
- Abbott Laboratories
- Sanofi-aventis Groupe
- Pfizer Inc.
- Boston Scientific Corporation
- Medtronic PLC
Browse Key Market Insights with Data Illustration:
In the News
-
Siemens Healthcare GmbH has launched the technologically-advanced multidisciplinary angiography system ARTIS icono. With its development, the company is expected to cater to different needs of cardiovascular interventions, interventional radiology, neuroradiology, and vascular interventions.
-
Pfizer Inc. has finally acquired Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company that is dedicated to the discovery, development, and delivery of life-changing treatments for patients diagnosed with sickle cell disease (SCD). The acquisition is anticipated to broaden the offerings provided by the company.
